What is the role of empirical treatment for suspected invasive candidiasis in non-neutropenic non transplanted patients in the intensive care unit?-Empiricus strikes back!
作者信息
Bretonnière Cédric, Lakhal Karim, Lepoivre Thierry, Boutoille David, Morio Florent
机构信息
CHU Nantes, PHU3, Medical Intensive Care Unit, place A. Ricordeau, Nantes, F-44093, France; ; Nantes University, UPRES EA 3826, Laboratory of clinical and experimental therapeutics of infections, IRS2-Nantes Biotech, F-44200, France.
CHU Nantes, PHU3, General Surgical Intensive Care Unit, Anesthesiology Department, Laënnec Hospital, place A. Ricordeau, Nantes, F-44093, France.
出版信息
J Thorac Dis. 2016 Dec;8(12):E1719-E1722. doi: 10.21037/jtd.2016.12.99.
Abstract
摘要
相似文献
1
What is the role of empirical treatment for suspected invasive candidiasis in non-neutropenic non transplanted patients in the intensive care unit?-Empiricus strikes back!
J Thorac Dis. 2016 Dec;8(12):E1719-E1722. doi: 10.21037/jtd.2016.12.99.
2
[Antifungal treatment for suspected or proved candidiasis in the critically ill].
Ann Fr Anesth Reanim. 2014 Apr;33(4):232-9. doi: 10.1016/j.annfar.2014.02.016. Epub 2014 Mar 27.
3
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA. 2016 Oct 18;316(15):1555-1564. doi: 10.1001/jama.2016.14655.
4
Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
Ann Intern Med. 2005 Dec 20;143(12):857-69. doi: 10.7326/0003-4819-143-12-200512200-00004.
5
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant - non-neutropenic adult ICU patients.
Int J Infect Dis. 2017 Jan;54:31-33. doi: 10.1016/j.ijid.2016.11.403. Epub 2016 Nov 18.
6
Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit.
Value Health. 2017 Dec;20(10):1319-1328. doi: 10.1016/j.jval.2017.06.009. Epub 2017 Aug 7.
7
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment.
Intensive Care Med. 2009 Feb;35(2):206-14. doi: 10.1007/s00134-008-1339-6. Epub 2008 Oct 30.
8
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Intensive Care Med. 2015 Nov;41(11):1931-40. doi: 10.1007/s00134-015-4053-1. Epub 2015 Sep 14.
9
Early diagnosis of candidiasis in non-neutropenic critically ill patients.
J Infect. 2004 Feb;48(2):181-92. doi: 10.1016/s0163-4453(03)00120-8.
10
EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Rev Iberoam Micol. 2014 Jul-Sep;31(3):157-75. doi: 10.1016/j.riam.2014.06.001. Epub 2014 Jun 21.
本文引用的文献
1
Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant .
J Thorac Dis. 2016 Oct;8(10):2784-2792. doi: 10.21037/jtd.2016.10.29.
2
Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
Clin Microbiol Infect. 2017 Feb;23(2):117.e1-117.e8. doi: 10.1016/j.cmi.2016.10.001. Epub 2016 Oct 13.
3
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA. 2016 Oct 18;316(15):1555-1564. doi: 10.1001/jama.2016.14655.
4
The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
Transpl Infect Dis. 2016 Dec;18(6):921-931. doi: 10.1111/tid.12613. Epub 2016 Nov 14.
5
Long term complications following 54 consecutive lung transplants.
J Thorac Dis. 2016 Jun;8(6):1234-44. doi: 10.21037/jtd.2016.05.03.
6
The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary.
J Heart Lung Transplant. 2016 Mar;35(3):261-282. doi: 10.1016/j.healun.2016.01.007. Epub 2016 Jan 19.
7
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
8
Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
J Infect. 2016 Jan;72(1):103-11. doi: 10.1016/j.jinf.2015.09.041. Epub 2015 Oct 28.
9
Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
J Antimicrob Chemother. 2015 Nov;70(11):3107-15. doi: 10.1093/jac/dkv241. Epub 2015 Aug 25.
10
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality.
Intensive Care Med. 2015 Sep;41(9):1601-10. doi: 10.1007/s00134-015-3866-2. Epub 2015 May 19.
Zotero 插件